FIELD: medicine.
SUBSTANCE: there are presented drug derivatives wherein said derivatives contain a H2S-releasing fragment of 4-hydroxythiobenzamide which is either covalently bond with the drug, or forms a pharmaceutically acceptable salt with the antilipidemic drug.
EFFECT: compounds show higher activity, or reduced side effects.
5 cl, 26 ex, 22 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| HYDROSULFIDE DERIVATIVES OF NON-STEROID ANTI-INFLAMMATORY DRUGS | 2007 |
|
RU2468019C2 |
| 4- OR 5-AMINOSALICYLIC ACID DERIVATIVES | 2006 |
|
RU2414476C2 |
| DERIVATIVE OF HYALURONIC ACID AND MEDICAL AGENT THAT CONTAINS IT | 2005 |
|
RU2390529C2 |
| NITROESTERS EXHIBITING ANTI-INFLAMMATORY AND/OR ANALGETIC ACTIVITY, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITIONS | 1994 |
|
RU2136653C1 |
| CO-CRYSTALLINE FORMS OF TRAMADOL AND NSAID | 2009 |
|
RU2599717C2 |
| AMIDINES AND THEIR DERIVATIVE, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | 2004 |
|
RU2375346C2 |
| ANALGESIC COMPOSITIONS | 2019 |
|
RU2820449C2 |
| PHENYLCARBAMATES AND USE THEREOF AS ENZYME INHIBITORS OF HYDROLASES OF FATTY ACID AMIDES (FAAH) AND DOPAMINE RECEPTOR D3 (D3DR) MODULATORS | 2014 |
|
RU2693457C2 |
| CYSTATHIONINE-G-LYASE (CSE) INHIBITORS | 2013 |
|
RU2640418C2 |
| NITROCOMPOUNDS AND PHARMACEUTICAL COMPOSITION SHOWING ANTI-INFLAMMATORY AND ANTITHROMBOTIC ACTIVITY | 1996 |
|
RU2165921C2 |
